Prognostic relevance of left atrial dysfunction in heart failure with preserved ejection fraction

Circulation: Heart Failure

Volumn 9, Issue 4, 2016, Pages

  Santos, Angela B S ^a,b   Roca, Gabriela Querejeta ^a   Claggett, Brian ^a   Sweitzer, Nancy K ^c   Shah, Sanjiv J ^d   Anand, Inder S ^e   Fang, James C ^f   Zile, Michael R ^g   Pitt, Bertram ^h   Solomon, Scott D ^a   Shah, Amil M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSITY OF ARIZONA   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e VA MEDICAL CENTER   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^h UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

atrial strain; diastolic heart failure; echocardiography; prognosis

Indexed keywords

ADVERSE OUTCOME; AGED; ARTICLE; ATRIAL FIBRILLATION; BODY SURFACE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART ATRIUM FUNCTION; HEART DISEASE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE REVASCULARIZATION; HEART RATE; HEMATOCRIT; HUMAN; HYPERTENSION; LEFT ATRIAL DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM; SPECKLE TRACKING ECHOCARDIOGRAPHY; SYSTOLIC BLOOD PRESSURE; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECTS; HEART ATRIUM; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HOSPITALIZATION; MECHANICAL STRESS; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; RISK FACTOR; SYSTOLE; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

MINERALOCORTICOID ANTAGONIST;

AGED; AGED, 80 AND OVER; ATRIAL FUNCTION, LEFT; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART ATRIA; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MINERALOCORTICOID RECEPTOR ANTAGONISTS; RISK FACTORS; STRESS, MECHANICAL; STROKE VOLUME; SYSTOLE; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84964546326     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.115.002763     Document Type: Article

References (29)

1. Iglesias-Garriz I, Olalla-Gómez C, Garrote C, López-Benito M, Martín J, Alonso D, Rodríguez MA, Contribution of right ventricular dysfunction to heart failure mortality: a meta-Analysis. Rev Cardiovasc Med 2012 13 e62 e69
2. Mohammed SF, Hussain I, AbouEzzeddine OF, Abou Ezzeddine OF, Takahama H, Kwon SH, Forfia P, Roger VL, Redfield MM, Right ventricular function in heart failure with preserved ejection fraction: a community-based study. Circulation 2014 130 2310 2320. doi: 10.1161/CIRCULATIONAHA.113.008461
3. Melenovsky V, Hwang SJ, Lin G, Redfield MM, Borlaug BA, Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J 2014 35 3452 3462. doi: 10.1093/eurheartj/ehu193
4. Shah SJ, Katz DH, Selvaraj S, Burke MA, Yancy CW, Gheorghiade M, Bonow RO, Huang CC, Deo RC, Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation 2015 131 269 279. doi: 10.1161/CIRCULATIONAHA.114.010637
5. Bursi F, McNallan SM, Redfield MM, Nkomo VT, Lam CS, Weston SA, Jiang R, Roger VL, Pulmonary pressures and death in heart failure: a community study. J Am Coll Cardiol 2012 59 222 231. doi: 10.1016/j.jacc.2011.06.076
6. Kjaergaard J, Akkan D, Iversen KK, Kjoller E, Køber L, Torp-Pedersen C, Hassager C, Prognostic importance of pulmonary hypertension in patients with heart failure. Am J Cardiol 2007 99 1146 1150. doi: 10.1016/j.amjcard.2006.11.052
7. Guazzi M, Bandera F, Pelissero G, Castelvecchio S, Menicanti L, Ghio S, Temporelli PL, Arena R, Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis. Am J Physiol Heart Circ Physiol 2013 305 H1373 H1381. doi: 10.1152/ajpheart.00157.2013
8. Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, Deswal A, Stevenson LW, Givertz MM, Ofili EO, O'Connor CM, Felker GM, Goldsmith SR, Bart BA, McNulty SE, Ibarra JC, Lin G, Oh JK, Patel MR, Kim RJ, Tracy RP, Velazquez EJ, Anstrom KJ, Hernandez AF, Mascette AM, Braunwald E, RELAX Trial Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 2013 309 1268 1277. doi: 10.1001/jama.2013.2024
9. Forfia PR, Borlaug BA, Letter by Forfia and Borlaug regarding article, "Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study." Circulation 2012 125 e408; author reply e409 e408; author reply e410. doi: 10.1161/CIRCULATIONAHA.111.064584
10. Chatterjee NA, Steiner J, Lewis GD, It is time to look at heart failure with preserved ejection fraction from the right side. Circulation 2014 130 2272 2277. doi: 10.1161/CIRCULATIONAHA.114.013536
11. Redfield MM, Borlaug BA, Lewis GD, Mohammed SF, Semigran MJ, Lewinter MM, Deswal A, Hernandez AF, Lee KL, Braunwald E, Heart Failure Clinical Research Network PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design. Circ Heart Fail 2012 5 653 659. doi: 10.1161/CIRCHEARTFAILURE.112.969071
12. Qureshi MY, Eidem BW, Reece CL, O'Leary PW, Two-dimensional measurement of tricuspid annular plane systolic excursion in children: can it substitute for an m-mode assessment? Echocardiography 2015 32 528 534. doi: 10.1111/echo.12687
13. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB, Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010 23 685 713; quiz 786. doi: 10.1016/j.echo.2010.05.010
14. Mohammed SF, Borlaug BA, McNulty S, Lewis GD, Lin G, Zakeri R, Semigran MJ, LeWinter M, Hernandez AF, Braunwald E, Redfield MM, Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Circ Heart Fail 2014 7 580 589. doi: 10.1161/CIRCHEARTFAILURE.114.001192
15. Shah AM, Claggett B, Sweitzer NK, Shah SJ, Anand IS, O'Meara E, Desai AS, Heitner JF, Li G, Fang J, Rouleau J, Zile MR, Markov V, Ryabov V, Reis G, Assmann SF, McKinlay SM, Pitt B, Pfeffer MA, Solomon SD, Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial. Circ Heart Fail 2014 7 740 751. doi: 10.1161/CIRCHEARTFAILURE.114.001583
16. Alam M, Samad BA, Hedman A, Frick M, Nordlander R, Cardioversion of atrial fibrillation and its effect on right ventricular function as assessed by tricuspid annular motion. Am J Cardiol 1999 84 1256 1258, A8
17. Lewis GD, Shah RV, Pappagianopolas PP, Systrom DM, Semigran MJ, Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone. Circ Heart Fail 2008 1 227 233. doi: 10.1161/CIRCHEARTFAILURE.108.785501
18. Andersen MJ, Hwang SJ, Kane GC, Melenovsky V, Olson TP, Fetterly K, Borlaug BA, Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction. Circ Heart Fail 2015 8 542 550. doi: 10.1161/CIRCHEARTFAILURE.114.002114
19. Hoendermis ES, Liu LC, Hummel YM, van der Meer P, de Boer RA, Berger RM, van Veldhuisen DJ, Voors AA, Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial. Eur Heart J 2015 36 2565 2573. doi: 10.1093/eurheartj/ehv336
20. Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, Tawakol A, Gerszten RE, Systrom DM, Bloch KD, Semigran MJ, Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation 2007 116 1555 1562. doi: 10.1161/CIRCULATIONAHA.107.716373
21. Guazzi M, Samaja M, Arena R, Vicenzi M, Guazzi MD, Long-Term use of sildenafil in the therapeutic management of heart failure. J Am Coll Cardiol 2007 50 2136 2144. doi: 10.1016/j.jacc.2007.07.078
22. Guazzi M, Vicenzi M, Arena R, Guazzi MD, PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study. Circ Heart Fail 2011 4 8 17. doi: 10.1161/CIRCHEARTFAILURE.110.944694
23. Guazzi M, Tumminello G, Di Marco F, Fiorentini C, Guazzi MD, The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure. J Am Coll Cardiol 2004 44 2339 2348. doi: 10.1016/j.jacc.2004.09.041
24. Lewis GD, Lachmann J, Camuso J, Lepore JJ, Shin J, Martinovic ME, Systrom DM, Bloch KD, Semigran MJ, Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation 2007 115 59 66. doi: 10.1161/CIRCULATIONAHA.106.626226
25. Guazzi M, Vicenzi M, Arena R, Guazzi MD, Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study. Circulation 2011 124 164 174. doi: 10.1161/CIRCULATIONAHA.110.983866
26. Boilson BA, Schirger JA, Borlaug BA, Caveat medicus! Pulmonary hypertension in the elderly: a word of caution. Eur J Heart Fail 2010 12 89 93. doi: 10.1093/eurjhf/hfp171
27. Semigran MJ, Cockrill BA, Kacmarek R, Thompson BT, Zapol WM, Dec GW, Fifer MA, Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol 1994 24 982 988
28. Shah AM, Shah SJ, Anand IS, Sweitzer NK, O'Meara E, Heitner JF, Sopko G, Li G, Assmann SF, McKinlay SM, Pitt B, Pfeffer MA, Solomon SD, TOPCAT Investigators Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial. Circ Heart Fail 2014 7 104 115. doi: 10.1161/CIRCHEARTFAILURE.113.000887
29. Solomon SD, Zile M, Pieske B, Voors A, Shah A, Kraigher-Krainer E, Shi V, Bransford T, Takeuchi M, Gong J, Lefkowitz M, Packer M, McMurray JJ, Prospective comparison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investigators The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial. Lancet 2012 380 1387 1395. doi: 10.1016/S0140-6736(12)61227-6